BIOLASE, INC

BIOLQ

Explore Our Financial Data > Companies > California Companies > BIOLASE, INC

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	BIOLQ
CIK	0000811240
SIC	3843
Sector	Manufacturing
Industry Category	Medical Equipment
Industry Group	Surgical, Medical, And Dental Instruments And Supplies

Contact

Address	27042 TOWNE CENTRE DRIVE, SUITE 270, FOOTHILL RANCH, CA, 92610
Website	biolase.com
Phone	949-361-1200
CEO	John R. Beaver
Employees	160

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$46.03 million
Pre-Tax Income	$-16.00 million
Net Income	$-16.04 million
Net Income to Common	$-15.97 million
EPS	$-0.44

View All

Balance Sheet

Cash	$3.44 million
Assets	$27.24 million
Liabilities	$32.12 million
Common Equity	$-5.23 million
Liabilities & Equity	$27.24 million

View All

Cash Flow Statement

Net Income	$-16.04 million
Cash From Operating Activities	$-13.43 million
Cash From Investing Activities	$288,000.00
Cash From Financing Activities	$8.59 million
Change in Cash	$-4.36 million

View All

Calculations

NOPAT	$-9.46 million
EBITDA	$-10.50 million
Price to Earnings	N/A
Price to Book	N/A
ROE	-3197.81%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

BIOLASE Announces Delisting from Nasdaq

LAKE FOREST, CA / ACCESSWIRE / June 18, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a global leader in dental lasers, today announced that the Company received a notice from Nasdaq that it has determined to delist the shares of the Company's common stock ...

Article Link

Q1 2024 BIOLASE Inc Earnings Call

Article Link

Biolase Inc (BIOL) Q1 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst Economic ...

Discover how Biolase Inc navigates market dynamics with robust revenue projections and significant operational efficiencies.

Article Link

Biolase Reports 2024 First Quarter Results; Reiterates Full-Year 2024 Guidance For Revenue Growth and Profitability

Increased Adoption of Dental Lasers and Improved Cost Structure Position Company for Sustained Long Term Growth and Success LAKE FOREST, CA / ACCESSWIRE / May 13, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), a leader in dental laser technology, today reported ...

Article Link

BIOLASE to Report First Quarter 2024 Results on May 13, 2024

LAKE FOREST, CA / ACCESSWIRE / May 6, 2024 / BIOLASE, Inc. (NASDAQ:BIOL), the globally recognized leader in dental laser technology, today announced that it will release first quarter 2024 financial and operating results on Monday, May 13, 2024, after ...

Article Link